http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105213482-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105213482-B |
| titleOfInvention | A kind of anti diabetes and kidney disease active material liposome powder for injection and preparation method thereof |
| abstract | The invention belongs to biological active matter preparation and preparation method thereof technical fields, more particularly to a kind of anti diabetes and kidney disease activity composite lipidosome and preparation method thereof, the active material of the liposome powder for injection is by mulberry leaf brass: polysaccharides: the mass ratio of ginkgo leaf brass mixes for 2.2-3.5:2.8-3.7:1.The present invention is using ginko leaves flavone, flavones in mulberry leaves and polysaccharides compatibility as liposome powder for injection made from active material embedded object, encapsulation rate is up to 90% or more, partial size is small and uniform, with targeting and lymph directionality, retention time of the drug in body circulation is increased, the bioavilability of active material is improved, toxicity is low, therapeutic effect is good, provides more optional scheme to treat the medical field of Diabetic Nephropathy patients；Liposome powder for injection slow release free drug prepared by the present invention improves stability, using liposome can and the characteristics of cell membrane fusion, drug is sent into cell interior. |
| priorityDate | 2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.